Used for both noninvasive and invasive monitoring of the fetus right before childbirth (antepartum), labor and delivery
Capabilities include nonstress testing from the 28th week of pregnancy and on, external monitoring of fetal heart rate via ultrasound, and uterine activity via the TOCO prove
Internal monitoring is available of fetal heart rate with DECG and uterine activity with IUPC (invasive component)